Senesco Technologies, Inc. (NYSE: SNT) reported results of H1N1 mouse influenza survival studies that were conducted in Dr. William Scheld's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE